Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel
A. Araújo; A. Barroso; B. Parente; C. Travancinha; E. Teixeira; F. Martelo; G. Fernandes; G. Paupério; H. Queiroga; I. Duarte; J.D. da Costa; M. Soares; P. Borralho; P. Costa; P. Chinita; T. Almodôvar; F. Barata;
Pulmonol. 2024;30:159-69
Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
M. Serino; C. Freitas; M. Martins; P. Ferreira; C. Cardoso; F. Veiga; V. Santos; D. Araújo; H. Novais-Bastos; A. Magalhães; H. Queiroga; G. Fernandes; V. Hespanhol;
Pulmonol. 2024;30:352-61
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
M.G.O. Fernandes; A.S. Vilariça; B. Fernandes; C. Camacho; C. Saraiva; F. Estevinho; H. Novais e Bastos; J.M. Lopes; P. Fidalgo; P. Garrido; S. Alves; S. Silva; T. Sequeira; F. Barata;
Pulmonol. 2024;30:4-7